Thomas Haberer Selected Research

Ions

10/2022	Biological Dose Optimization for Particle Arc Therapy Using Helium and Carbon Ions.
9/2022	Spot-scanning hadron arc (SHArc) therapy: A proof of concept using single- and multi-ion strategies with helium, carbon, oxygen, and neon ions.
1/2022	Combined DNA Damage Repair Interference and Ion Beam Therapy: Development, Benchmark, and Clinical Implications of a Mechanistic Biological Model.
1/2022	Results of a prospective randomized trial on long-term effectiveness of protons and carbon ions in prostate cancer: LEM I and α/β = 2 Gy overestimates the RBE.
5/2021	Spot-Scanning Hadron Arc (SHArc) Therapy: A Study With Light and Heavy Ions.
7/2019	Biophysical modeling and experimental validation of relative biological effectiveness (RBE) for 4He ion beam therapy.
1/2019	Active-Scanned Protons and Carbon Ions in Cancer Treatment of Patients With Cardiac Implantable Electronic Devices: Experience of a Single Institution.
10/2018	Fast robust dose calculation on GPU for high-precision 1H, 4He, 12C and 16O ion therapy: the FRoG platform.
1/2018	Proton and helium ion radiotherapy for meningioma tumors: a Monte Carlo-based treatment planning comparison.
1/2018	High control rates of proton- and carbon-ion-beam treatment with intensity-modulated active raster scanning in 101 patients with skull base chondrosarcoma at the Heidelberg Ion Beam Therapy Center.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Haberer Research Topics

Disease

34	Neoplasms (Cancer) 01/2022 - 05/2002
9	Chordoma 10/2022 - 05/2002
8	Glioma (Gliomas) 01/2022 - 10/2010
8	Chondrosarcoma 01/2018 - 05/2002
7	Glioblastoma (Glioblastoma Multiforme) 10/2022 - 09/2010
6	Meningioma (Meningiomas) 01/2018 - 04/2010
6	Adenoid Cystic Carcinoma (Cylindroma) 02/2016 - 06/2003
5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 08/2011
4	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 02/2011
3	AIDS-Related Complex (ARC) 10/2022 - 05/2021
2	Adenocarcinoma 10/2022 - 09/2022
2	Hypoxia (Hypoxemia) 05/2021 - 12/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017 - 05/2012
2	Cardiac Arrhythmias (Arrythmia) 04/2015 - 04/2015
2	Brain Neoplasms (Brain Tumor) 10/2013 - 03/2012
1	Brain Injuries (Brain Injury) 01/2022
1	Lymphoma (Lymphomas) 07/2019
1	Thymoma (Thymic Carcinoma) 12/2018
1	Pain (Aches) 05/2016
1	Fatigue 05/2016
1	Fistula 05/2016
1	Mucositis 09/2015
1	Colonic Neoplasms (Colon Cancer) 11/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2012
1	Nocturia 08/2011
1	Dysuria 08/2011
1	Necrosis 11/2003

Drug/Important Bio-Agent (IBA)

39	CarbonIBA 10/2022 - 05/2002
30	IonsIBA 10/2022 - 05/2002
20	Protons (Proton)IBA 01/2022 - 07/2008
11	Biological ProductsIBA 10/2022 - 05/2002
6	HeliumIBA 10/2022 - 08/2016
4	Oxygen (Dioxygen)IBA 09/2022 - 01/2014
4	Gemcitabine FDA Link 01/2017 - 01/2012
3	Temozolomide (Temodar)FDA LinkGeneric 09/2013 - 09/2010
2	Radiation-Sensitizing AgentsIBA 01/2022 - 12/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2013 - 01/2012
2	CamptothecinIBA 11/2013 - 01/2012
1	1- methyl- 4- cyclohexyl- 1,2,3,6- tetrahydropyridineIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 12/2017
1	DNA-Activated Protein KinaseIBA 12/2017
1	temsirolimus FDA Link 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 11/2013
1	MethyltransferasesIBA 09/2013
1	IntegrinsIBA 05/2012
1	Fibronectins (Fibronectin)IBA 05/2012
1	VitronectinIBA 05/2012
1	Hematoxylin (Haematoxylon)IBA 11/2003
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2003

Therapy/Procedure

27	Therapeutics 10/2022 - 01/2011
24	Heavy Ion Radiotherapy 01/2022 - 05/2002
22	Radiotherapy 01/2021 - 05/2002
5	Re-Irradiation 03/2012 - 02/2004
4	Drug Therapy (Chemotherapy) 07/2013 - 10/2010
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2018 - 09/2015
1	Proton Therapy 01/2022
1	Molecular Targeted Therapy 01/2017
1	Operative Surgical Procedures 02/2016
1	Catheters 04/2015
1	Drug Tapering 02/2015
1	Chemoradiotherapy 09/2010
1	Aftercare (After-Treatment) 04/2010
1	Synchrotrons 08/2002